<p>Faheem Hasnain, Director at Kura Oncology Inc., has reported a disposal of common shares of the company, according to a recent SEC filing. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-314154), on December 10, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

KURA

<p>Faheem Hasnain, Director at Kura Oncology Inc., reported the disposal of common shares of the company, as per a recent SEC filing. The original content was published via EDGAR by Kura Oncology Inc. on December 10, 2025.</p>

Kura Oncology Director Faheem Hasnain Reports Disposal of Common Shares